DECAGLIM-MV1
Glimepiride 1 mg + Metformin 500 mg ER + Voglibose 0.2 mg
DECAGLIM-MV1
DECAGON PHARMACEUTICALS
- Dosage Form
- Tablets
- Packaging
- 10 x 10 Tablets / Blister Pack
Overview of DECAGLIM-MV1
DECAGLIM-MV1 Tablets combine Glimepiride (1 mg), Metformin Hydrochloride ER (500 mg), and Voglibose (0.2 mg). Scientifically formulated for the specialized management of postprandial hyperglycemia in Type 2 Diabetes Mellitus.
Indicated for Type 2 Diabetes patients with exaggerated postprandial glucose spikes, high carbohydrate diets, impaired glucose tolerance, and those uncontrolled on dual oral antidiabetic therapy.
"DECAGLIM-MV1 — In the Management of Post Prandial Hyperglycemia in Type II Diabetes."
Clinical Evidence Context: Primary Focus: Postprandial Hyperglycemia in Type 2 Diabetes Mellitus and Prevention of Glycemic Variability.
Diabetic Care
Tablets
More in Diabetic Care
View categoryDECAGLIM-M1
Glimepiride 1 mg + Metformin Hydrochloride ER 500 mg
DECAGLIM-M2
Glimepiride 2 mg + Metformin Hydrochloride ER 500 mg
DECAGLIM-MV2
Glimepiride 2 mg + Metformin 500 mg ER + Voglibose 0.2 mg